Pharma News

BACKGROUNDLorcaserin, a selective serotonin 2C receptor agonist that modulates appetite, has proven efficacy for weight management in overweight or obese patients.

Munich, Germany - 27 Aug 2018.

New 'micro-organs' have been discovered in the human body which could explain how we remember how to fight off illness.

The European and American medicines agencies have sent a letter to Saudi Crown Prince Mohammad bin Salman warning him of the dangers that the continuation of diplomatic disputes between the Kingdom an...

Pfizer Inc.

Shire’s Takhzyro has been approved in the US for the prevention of attacks of hereditary angioedema (HAE) in patients 12 years of age and older.

Roche has sold off rights to inclacumab to Global Blood Therapeutics, which intends to develop the treatment for vaso-occlusive crises (VOC) in patients with sickle cell disease (SCD).

A new anti-aging therapeutic in the clinical pipeline could stand to disrupt multibillion-dollar legacy franchises like AbbVie’s Humira and Amgen’s Enbrel.

(Reuters Health) - Life expectancy is declining in high-income countries worldwide, driven in part by the effects of the opioid epidemic on younger adults in the U.

BRISTOL and COPENHAGEN, 17 August 2018 ­- Ziylo and Novo Nordisk A/S today announced that Novo Nordisk has acquired all of the shares of Ziylo, a University of Bristol spin-out company based at Unit...

The U.

PHILADELPHIA--A universal flu vaccine that protects people against most influenza strains is one step closer to reality, with a study from the Perelman School of Medicine at the University of Pennsylv...